Denileukin diftitox, otherwise known as Ontak is an antineoplastic agent, an engineered protein combining Interleukin-2 and Diphtheria toxin. This can bind to Interleukin-2 receptors and introduce the diphtheria toxin into cells that express those receptors, killing the cells. In some Leukemias and Lymphomas malignant cells express these receptors, so denileukin diftitox can target these.
See more at Wikipedia.org...
[DEN-i-loo-kin DIF-ti-toks] A substance used to treat cutaneous T-cell lymphoma when other treatments have not worked. It is also being studied in the treatment of chronic lymphocytic leukemia that has not responded to treatment. It belongs to the family of drugs called biological therapy agents.
Free Download Now!
